Key result
Genetic testing in HCM enables preclinical disease detection and revolutionizes patient care.
Authors
Loading...
Key points are not available for this paper at this time.
Ingles et al. (2015) studied this question. Genetic testing in hypertrophic cardiomyopathy enables preclinical disease detection and has revolutionized the care of patients.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: